Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients
Identifieur interne : 000E43 ( France/Analysis ); précédent : 000E42; suivant : 000E44Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients
Auteurs : O. Vittecoq ; S. Pouplin ; K. Krzanowska ; F. Jouen-Beades ; J. F. Me Nard ; A. Gayet [France] ; A. Daragon ; F. Tron ; X. Le Loe TSource :
- Rheumatology [ 1462-0324 ] ; 2003-08.
English descriptors
- KwdEn :
Abstract
Objective. To evaluate the predictive value of clinical, biological and radiological parameters for the prognosis of rheumatoid arthritis (RA) in a community‐recruited cohort. Methods. Ninety‐one patients (mean age 49 yr, female/male ratio 2.9) with RA of limited duration (median 2 yr), 80% recruited from the community, were prospectively enrolled in 1996 (T1) and followed until 1999 (T2). Data collected at T1 were demographic characteristics, Ritchie articular index (RAI), extra‐articular manifestations, Health Assessment Questionnaire (HAQ) score, C‐reactive protein (CRP) and autoantibodies (autoAbs) [rheumatoid factors (RF), detected by latex fixation test and ELISA (IgM, IgA and IgG isotypes), anti‐filaggrin, detected by immunofluorescence (anti‐keratin antibodies, AKA; anti‐perinuclear factor antibodies, APF) and ELISA (anti‐citrullinated rat filaggrin antibodies, ACRFA), anti‐Sa, anti‐calpastatin recognizing the 27 C‐terminal fragment (ACAST‐C27) and domain I (ACAST‐DI), anti‐cardiolipin (ACL), antineutrophil cytoplasmic antibodies (ANCA), anti‐annexin V (aANX V) and anti‐Ro]. Hands were radiographed at T1 and T2, and read using the Sharp method as modified by van der Heijde. The main assessment criterion was progression of radiologically detected damage between T1 and T2. Results. At T1, RA activity was mild (RAI 11/78; mean CRP 14 mg/ml), with minor functional disability (HAQ 0.8/3) and mild X‐ray destruction (mean total Sharp score 9.2/280). At T1, 96% of the patients were on treatment (prednisone 72%, DMARDs 95%). The latex test detected autoAb in 46% of patients, RF‐IgM was detected in 51%, RF‐IgA in 36%, RF‐IgG in 32%, AKA in 33%, APF in 45%, ACRFA in 45%, ACAST‐C27 in 14%, ACAST‐DI in 5%, anti‐Sa in 22%, ACL in 3%, ANCA in 28%, aANX V in 9% and anti‐Ro in 2%. At T2, the mean total Sharp score was 22.9. According to univariate analysis, T1 parameters associated with the independent variable were RAI, HAQ, CRP, latex test positivity and T1 Sharp scores. Multivariate analysis retained only latex test positivity and, to a lesser degree, joint‐space narrowing score as independent predictors of radiological progression. Conclusion. RF is the main factor that can predict radiological progression in community cases of RA of limited duration.
Url:
DOI: 10.1093/rheumatology/keg257
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001474
- to stream Istex, to step Curation: 001474
- to stream Istex, to step Checkpoint: 000666
- to stream Main, to step Merge: 001517
- to stream Main, to step Curation: 001481
- to stream Main, to step Exploration: 001481
- to stream France, to step Extraction: 000E43
Links to Exploration step
ISTEX:528DB25936FC491CE06C9755ECEEC9690DCB631DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients</title><author><name sortKey="Vittecoq, O" sort="Vittecoq, O" uniqKey="Vittecoq O" first="O." last="Vittecoq">O. Vittecoq</name></author><author><name sortKey="Pouplin, S" sort="Pouplin, S" uniqKey="Pouplin S" first="S." last="Pouplin">S. Pouplin</name></author><author><name sortKey="Krzanowska, K" sort="Krzanowska, K" uniqKey="Krzanowska K" first="K." last="Krzanowska">K. Krzanowska</name></author><author><name sortKey="Jouen Eades, F" sort="Jouen Eades, F" uniqKey="Jouen Eades F" first="F." last="Jouen-Beades">F. Jouen-Beades</name></author><author><name sortKey="Me Nard, J F" sort="Me Nard, J F" uniqKey="Me Nard J" first="J. F." last="Me Nard">J. F. Me Nard</name></author><author><name sortKey="Gayet, A" sort="Gayet, A" uniqKey="Gayet A" first="A." last="Gayet">A. Gayet</name></author><author><name sortKey="Daragon, A" sort="Daragon, A" uniqKey="Daragon A" first="A." last="Daragon">A. Daragon</name></author><author><name sortKey="Tron, F" sort="Tron, F" uniqKey="Tron F" first="F." last="Tron">F. Tron</name></author><author><name sortKey="Le Loe T, X" sort="Le Loe T, X" uniqKey="Le Loe T X" first="X." last="Le Loe T">X. Le Loe T</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:528DB25936FC491CE06C9755ECEEC9690DCB631D</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1093/rheumatology/keg257</idno><idno type="url">https://api.istex.fr/document/528DB25936FC491CE06C9755ECEEC9690DCB631D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001474</idno><idno type="wicri:Area/Istex/Curation">001474</idno><idno type="wicri:Area/Istex/Checkpoint">000666</idno><idno type="wicri:doubleKey">1462-0324:2003:Vittecoq O:rheumatoid:factor:is</idno><idno type="wicri:Area/Main/Merge">001517</idno><idno type="wicri:Area/Main/Curation">001481</idno><idno type="wicri:Area/Main/Exploration">001481</idno><idno type="wicri:Area/France/Extraction">000E43</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients</title><author><name sortKey="Vittecoq, O" sort="Vittecoq, O" uniqKey="Vittecoq O" first="O." last="Vittecoq">O. Vittecoq</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Pouplin, S" sort="Pouplin, S" uniqKey="Pouplin S" first="S." last="Pouplin">S. Pouplin</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Krzanowska, K" sort="Krzanowska, K" uniqKey="Krzanowska K" first="K." last="Krzanowska">K. Krzanowska</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Jouen Eades, F" sort="Jouen Eades, F" uniqKey="Jouen Eades F" first="F." last="Jouen-Beades">F. Jouen-Beades</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Me Nard, J F" sort="Me Nard, J F" uniqKey="Me Nard J" first="J. F." last="Me Nard">J. F. Me Nard</name><affiliation><wicri:noCountry code="subField">and</wicri:noCountry></affiliation></author><author><name sortKey="Gayet, A" sort="Gayet, A" uniqKey="Gayet A" first="A." last="Gayet">A. Gayet</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Collège des Rhumatologues de Haute‐Normandie, Rouen</wicri:regionArea><placeName><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Daragon, A" sort="Daragon, A" uniqKey="Daragon A" first="A." last="Daragon">A. Daragon</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Tron, F" sort="Tron, F" uniqKey="Tron F" first="F." last="Tron">F. Tron</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Le Loe T, X" sort="Le Loe T, X" uniqKey="Le Loe T X" first="X." last="Le Loe T">X. Le Loe T</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology</title><title level="j" type="abbrev">Rheumatology</title><idno type="ISSN">1462-0324</idno><idno type="eISSN">1462-0332</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2003-08">2003-08</date><biblScope unit="volume">42</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="939">939</biblScope><biblScope unit="page" to="946">946</biblScope></imprint><idno type="ISSN">1462-0324</idno></series><idno type="istex">528DB25936FC491CE06C9755ECEEC9690DCB631D</idno><idno type="DOI">10.1093/rheumatology/keg257</idno><idno type="PII">1460-2172</idno><idno type="local">420939</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1462-0324</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Autoantibodies</term><term>Community‐based population</term><term>Prognosis</term><term>Radiological progression</term><term>Rheumatoid arthritis</term><term>Rheumatoid factor.</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objective. To evaluate the predictive value of clinical, biological and radiological parameters for the prognosis of rheumatoid arthritis (RA) in a community‐recruited cohort. Methods. Ninety‐one patients (mean age 49 yr, female/male ratio 2.9) with RA of limited duration (median 2 yr), 80% recruited from the community, were prospectively enrolled in 1996 (T1) and followed until 1999 (T2). Data collected at T1 were demographic characteristics, Ritchie articular index (RAI), extra‐articular manifestations, Health Assessment Questionnaire (HAQ) score, C‐reactive protein (CRP) and autoantibodies (autoAbs) [rheumatoid factors (RF), detected by latex fixation test and ELISA (IgM, IgA and IgG isotypes), anti‐filaggrin, detected by immunofluorescence (anti‐keratin antibodies, AKA; anti‐perinuclear factor antibodies, APF) and ELISA (anti‐citrullinated rat filaggrin antibodies, ACRFA), anti‐Sa, anti‐calpastatin recognizing the 27 C‐terminal fragment (ACAST‐C27) and domain I (ACAST‐DI), anti‐cardiolipin (ACL), antineutrophil cytoplasmic antibodies (ANCA), anti‐annexin V (aANX V) and anti‐Ro]. Hands were radiographed at T1 and T2, and read using the Sharp method as modified by van der Heijde. The main assessment criterion was progression of radiologically detected damage between T1 and T2. Results. At T1, RA activity was mild (RAI 11/78; mean CRP 14 mg/ml), with minor functional disability (HAQ 0.8/3) and mild X‐ray destruction (mean total Sharp score 9.2/280). At T1, 96% of the patients were on treatment (prednisone 72%, DMARDs 95%). The latex test detected autoAb in 46% of patients, RF‐IgM was detected in 51%, RF‐IgA in 36%, RF‐IgG in 32%, AKA in 33%, APF in 45%, ACRFA in 45%, ACAST‐C27 in 14%, ACAST‐DI in 5%, anti‐Sa in 22%, ACL in 3%, ANCA in 28%, aANX V in 9% and anti‐Ro in 2%. At T2, the mean total Sharp score was 22.9. According to univariate analysis, T1 parameters associated with the independent variable were RAI, HAQ, CRP, latex test positivity and T1 Sharp scores. Multivariate analysis retained only latex test positivity and, to a lesser degree, joint‐space narrowing score as independent predictors of radiological progression. Conclusion. RF is the main factor that can predict radiological progression in community cases of RA of limited duration.</div></front></TEI><affiliations><list><country><li>France</li></country><settlement><li>Rouen</li></settlement></list><tree><noCountry><name sortKey="Daragon, A" sort="Daragon, A" uniqKey="Daragon A" first="A." last="Daragon">A. Daragon</name><name sortKey="Jouen Eades, F" sort="Jouen Eades, F" uniqKey="Jouen Eades F" first="F." last="Jouen-Beades">F. Jouen-Beades</name><name sortKey="Krzanowska, K" sort="Krzanowska, K" uniqKey="Krzanowska K" first="K." last="Krzanowska">K. Krzanowska</name><name sortKey="Le Loe T, X" sort="Le Loe T, X" uniqKey="Le Loe T X" first="X." last="Le Loe T">X. Le Loe T</name><name sortKey="Me Nard, J F" sort="Me Nard, J F" uniqKey="Me Nard J" first="J. F." last="Me Nard">J. F. Me Nard</name><name sortKey="Pouplin, S" sort="Pouplin, S" uniqKey="Pouplin S" first="S." last="Pouplin">S. Pouplin</name><name sortKey="Tron, F" sort="Tron, F" uniqKey="Tron F" first="F." last="Tron">F. Tron</name><name sortKey="Vittecoq, O" sort="Vittecoq, O" uniqKey="Vittecoq O" first="O." last="Vittecoq">O. Vittecoq</name></noCountry><country name="France"><noRegion><name sortKey="Gayet, A" sort="Gayet, A" uniqKey="Gayet A" first="A." last="Gayet">A. Gayet</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E43 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000E43 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:528DB25936FC491CE06C9755ECEEC9690DCB631D
|texte= Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients
}}
| This area was generated with Dilib version V0.6.25. |  |